Prevention of thromboembolism after cardioversion of recent-onset atrial fibrillation: Brief is not always safe

Journal of the American College of Cardiology

Volumn 62, Issue 13, 2013, Pages 1193-1194

  Dagres, Nikolaos ^a   Kornej, Jelena ^b,c   Hindricks, Gerhard ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

anticoagulation; atrial fibrillation; cardioversion stroke; thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ANTICOAGULATION; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; NOTE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINUS RHYTHM; STUNNED HEART MUSCLE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

EID: 84884357870     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.06.019     Document Type: Editorial

References (17)

1. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
2. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
3. P.K. Mason, M.A. Wood, D. Lake, and J.P. DiMarco Influence of the randomized trials, AFFIRM and RACE, on the management of atrial fibrillation in two university medical centers Am J Cardiol 95 2005 1248 1250
4. R. Ionescu-Ittu, M. Abrahamowicz, and C.A. Jackevicius Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation Arch Intern Med 172 2012 997 1004
5. C.B. De Vos, G. Breithardt, and A.J. Camm Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy Am Heart J 163 2012 887 893
6. J.S. Chinitz, J.L. Halperin, V.Y. Reddy, and V. Fuster Rate or rhythm control for atrial fibrillation: update and controversies Am J Med 125 2012 1049 1056
7. N. Dagres, T. Lewalter, G.Y. Lip, L. Pison, A. Proclemer, and C. Blomström-Lundqvist Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: the European Heart Rhythm Association survey Europace 15 2013 478 481
8. R.A. Grimm, W.J. Stewart, and J.D. Maloney Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography J Am Coll Cardiol 22 1993 1359 1366
9. M. Berger, and P. Schweitzer Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis Am J Cardiol 82 1998 1545 1547
10. K.J. Harjai, S.K. Mobarek, J. Cheirif, L.M. Boulos, J.P. Murgo, and F. Abi-Samra Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation J Am Coll Cardiol 30 1997 481 486
11. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
12. J.L. Anderson, J.L. Halperin, and N.M. Albert Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 1935 1944
13. W.J. Manning, D.I. Silverman, and S.E. Katz Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation J Am Coll Cardiol 23 1994 1535 1540
14. P.B. Sparks, S. Jayaprakash, H.G. Mond, J.K. Vohra, L.E. Grigg, and J.M. Kalman Left atrial mechanical function after brief duration atrial fibrillation J Am Coll Cardiol 33 1999 342 349
15. K.E.J. Airaksinen, T. Grönberg, and I. Nuotio Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV study J Am Coll Cardiol 62 2013 1187 1192
16. T. Fetsch, P. Bauer, and R. Engberding Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial Eur Heart J 25 2004 1385 1394
17. C.W. Israel, G. Grönefeld, J.R. Ehrlich, Y.G. Li, and S.H. Hohnloser Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care J Am Coll Cardiol 43 2004 47 52